Spike Protein Detox in a Breast Cancer Patient: A Case Report
Spike Protein Detox in a Breast Cancer Patient: A Case Report A targeted intervention that took spike IgG from ~100...
Case Reports and studies
TARGETED METABOLIC CANCER THERAPY CASE REPORT: Borderline High-Risk Prostate Cancer Shows Rapid PSA Reduction (–46%), Near-Complete Inflammation Resolution (–99%), and Hormonal Rebalancing Within 1 Month
Patient profile Age: 65 yearsSex: Male Clinical History Long-standing chronic prostatitis Prior 12-core biopsy (2024) Persistent PSA elevation Diagnosis (2025) Cancer type: Prostate cancer Histology: Acinar...
TARGETED METABOLIC CANCER THERAPY CASE REPORT: Stage IV Pancreatic Cancer With Liver Metastases Achieves No Evidence of Disease (NED) After 14 Months of Combined Immunotherapy and Metabolic Intervention
BACKGROUND Patient: 59-year-old maleCancer Type: Pancreatic adenocarcinomaStage at Diagnosis: Stage IVMetastatic Site: LiverTime Since Diagnosis: ~14 months Pancreatic cancer is...
TARGETED METABOLIC CANCER THERAPY CASE REPORT: Metastatic Poorly Differentiated NSCLC Shows ~80% Reduction in Tumor Activity Markers and Complete Inflammation Reversal Over 4 Months
BACKGROUND Diagnosis: Metastatic poorly differentiated non-small cell lung adenocarcinoma (NSCLC)Primary tumor: Right lower lobeStage: Advanced metastatic disease Documented Metastatic Spread...
TARGETED METABOLIC CANCER THERAPY CASE REPORT (Ivermectin, Fenbendazole, CDS, Ketogenic diet & more…), 34% reduction in PSA in 4 weeks.
64-Year-Old Male With Metastatic Prostate Cancer, Lung Masses & Liver Lesions — Baseline Status and 4-Week Metabolic Response BACKGROUND PET/CT...
